Novartis AG (NYSE:NVS)

104.28
Delayed Data
As of Apr 24
 -1.22 / -1.16%
Today’s Change
83.71
Today|||52-Week Range
105.82
+12.54%
Year-to-Date
Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog
Apr 24 / Zacks.com
Immune Cell Cancer Immunotherapy Passes First Safety Test in Solid Tumors
Apr 19 / TheStreet.com
Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog
Apr 24 / Zacks.com
3 Megatrends in Healthcare
Apr 19 / MotleyFool.com
Novartis AG (NVS) Earnings Report: Q1 2015 Conference Call Transcript
Apr 24 / TheStreet.com
Meet the Game-Changing Drug Designed to Fight America's Leading Cause of Death
Apr 18 / MotleyFool.com
Novartis Posts Higher Q1 Profit
Apr 23 / Benzinga
Novartis and Momenta Get FDA Nod For Generic Copaxone - Analyst Blog
Apr 17 / Zacks.com
Novartis (NVS) Beats on Earnings & Revenues - Tale of the Tape
Apr 23 / Zacks.com
Momenta Pharmaceuticals Inc. (MNTA) in Focus: Stock Jumps 6.1% - Tale of the Tape
Apr 17 / Zacks.com
3 Soaring Biotech Stocks Under $10 -- Are They Buys?
Apr 22 / MotleyFool.com
Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog
Apr 16 / Zacks.com
Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog
Apr 22 / Zacks.com
Why Momenta Pharmaceuticals Inc. Shares Are Surging Higher
Apr 16 / MotleyFool.com
Will Eli Lilly (LLY) Beat Earnings in 1Q Despite Generics? - Analyst Blog
Apr 21 / Zacks.com
3 Potential Blockbuster Drugs That Could Be Approved Before Year's End
Apr 16 / MotleyFool.com
Will Novartis' (NVS) Earnings Disappoint This Quarter? - Analyst Blog
Apr 21 / Zacks.com
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
Apr 15 / Zacks.com
Novartis (NVS) Hits New Lifetime High Today
Apr 21 / TheStreet.com
3 Biotech Stocks That May Disappear Before 2020
Apr 15 / MotleyFool.com
Why Shares of Juno Therapeutics Inc. and Kite Pharma Inc. Crashed Today
Apr 20 / MotleyFool.com
How Amgen Could Side-Step The Sting of Patent Expiration
Apr 11 / MotleyFool.com
CAR-T Therapy Stocks Hit Hard Following AACR Data
Apr 20 / Benzinga
 

To view my watchlist

Not a member yet?

Sign up now for a free account